Videos / Oncology case studies: How two life sciences companies applied real-world evidence to drive innovation (01:01:13)

Oncology case studies: How two life sciences companies applied real-world evidence to drive innovation (01:01:13)

Flatiron Health

14 July 2026

Last Updated

1 January 2025

Oncology real-world data and evidence (RWD/E) can be used across the entire product life cycle, from clinical research and development to launch and post-marketing.

In this webinar, experts from Flatiron Health, Eli Lilly, and GSK:

Highlight how RWE was leveraged to understand unmet need and treatment patterns to support FDA accelerated approval of a new drug for mantle cell lymphoma

Demonstrate the impact of RWE in assessing real-world outcomes and comparative effectiveness post drug launch for patients with recurrent ovarian cancer

Organisation

Flatiron Health

FLATIRON HEALTH® is a healthtech company dedicated to improving cancer treatment and advancing research. As the pioneer in real-world evidence for oncology, they provide technology and services to support patient care and make every person’s story count. They partner with hundreds of cancer centers, 20+ top global developers of oncology therapeutics, and researchers and regulators around the world.